top of page



University of Gothenburg

University of Gothenburg (UGOT, Sweden), is one of the largest universities in Scandinavia. One of its areas of international strength is vaccines and related immunology, with world-leading expertise in mucosal vaccines and mucosal immunology. Its achievements include e.g. (i) the development of the first WHO-prequalified oral vaccine against cholera, and an oral vaccine against ETEC diarrhoea in phase 2b clinical testing; (ii) the development of many of the most used immunoassays in vaccine research (e.g. first use of ELISA in vaccinology, development of the ELISPOT method for assaying antibody- and cytokine-secreting cells, and the intestinal lavage method for measuring intestinal antibodies); and (iii) phase 1 to phase 4 clinical testing of vaccines in both high- and low-income settings. The UGOT team consists of senior experts with proven world-leading experience and expertise in oral vaccine and immunology R&D and support staff. UGOT has a wide global partner network including organisations engaged in vaccine R&D from both public and private sector and has long experience of participation and leadership in numerous EU- and otherwise funded vaccine projects.

bottom of page